News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Klein Matthew B.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/26/2023 |
4
| Klein Matthew B. (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 17,153 restricted stock units
@ $0 |
|
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2023 |
4
| Klein Matthew B. (COO) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 2,273 shares
@ $42.9329, valued at
$97.6k
Sold 2,244 shares
@ $44.3596, valued at
$99.5k
|
|
| 01/11/2023 |
4
| Klein Matthew B. (COO) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 731 shares
@ $41.6562, valued at
$30.5k
|
|
| 01/09/2023 |
4
| Klein Matthew B. (COO) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 26,000 shares
@ $0
Granted 65,000 options to buy
@ $39.42, valued at
$2.6M
|
|
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2022 |
4
| Klein Matthew B. (COO) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 897 shares
@ $42.515, valued at
$38.1k
|
|
| 01/11/2022 |
4
| Klein Matthew B. (COO) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 775 shares
@ $38.525, valued at
$29.9k
Granted 21,000 shares
@ $0
Granted 20,000 shares
@ $0
Granted 52,500 options to buy
@ $38.1, valued at
$2M
Granted 50,000 options to buy
@ $38.1, valued at
$1.9M
|
|
| 06/28/2021 |
4
| Klein Matthew B. (Director) has filed a Form 4 on ClearPoint Neuro, Inc.|
Txns:
| Granted 3,003 shares
@ $0
Granted 6,006 options to buy
@ $19.98, valued at
$120k
|
|
| 04/21/2021 |
4
| Klein Matthew B. (Chief Development Officer) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 859 shares
@ $48.168, valued at
$41.4k
Sold 1,444 shares
@ $46.582, valued at
$67.3k
Sold 197 shares
@ $47.919, valued at
$9.4k
|
|
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2020 |
4
| Klein Matthew B. (Chief Development Officer) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 10,000 shares
@ $0
Granted 50,000 options to buy
@ $47.49, valued at
$2.4M
|
|
| 04/17/2020 |
3
| Klein Matthew B. (Chief Development Officer) has filed a Form 3 on PTC THERAPEUTICS, INC. |
| 04/17/2020 |
3
| Klein Matthew B. (Director) has filed a Form 3 on ClearPoint Neuro, Inc. |
|
|